What is Tesamorelin?
Research use only. The summary below reflects reports in research literature. It is not medical advice or instructions for human use. Tesamorelin is sold strictly for research and analytical purposes.
Ordering from the EU? See Tesamorelin on our EU store on our European store, with EU delivery.
In Deutschland? See Tesamorelin on our EU store on Body Pharm Deutschland, with German delivery.
In Czechia? See Tesamorelin on our EU store on Body Pharm Česko, with delivery within Czechia.
In Spain? See Tesamorelin on our EU store on Body Pharm España, with delivery within Spain.
What is Tesamorelin?
Tesamorelin is a stabilised GHRH (growth-hormone-releasing hormone) analogue, supplied for research as a pre-filled multi-dose pen. Unlike the weekly incretins, it is dosed daily.
It is studied for its effect on the growth-hormone axis and on visceral (deep abdominal) fat in metabolic research. Research outcomes vary with dose and duration.
Reported side effects
- Injection-site redness or itching — the most commonly reported effect.
- Fluid retention and joint or muscle aches (GH-axis related) at higher doses.
- Changes in glucose handling reported in the research literature.
How to dose Tesamorelin
Dosed once daily in the evening — start at 0.25 mg and titrate up to a 2 mg/day maximum, run as an 8–12 week cycle with 4 weeks off. The multi-dose pen sets each dose precisely; no mixing.
Read the full Tesamorelin dosing protocolHow to get Tesamorelin
The Body Pharm Tesamorelin pen is a sealed, HPLC-tested device with a published Certificate of Analysis and free, discreet UK delivery. Sold strictly for research use only.
Cost per month
Confirmed on release — reserve free on the waitlist, no payment taken.
Published HPLC COA · free discreet UK delivery
All Body Pharm products are sold strictly for research and analytical purposes only. Not for human consumption.